ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

National Coalition An Education Group, Chairman Says

May 3, 1985

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003